SB-480848 In Subjects With Coronary Heart Disease

Clinical trial NCT00269048 · COMPLETED

Trial details

NCT number: NCT00269048
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2005-11-01
Primary completion: 2006-09-01
Enrollment: 969

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.